Biocryst Pharmaceuticals (BCRX) Gross Margin Growth (3y) (2013 - 2026)
Biocryst Pharmaceuticals (BCRX) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.43 Bn | 2.08 Bn | 214.41 Mn | -68.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -68.00 |
| Mar 31, 2026 | -208.00 |
| Dec 31, 2025 | -134,192.00 |
| Sep 30, 2025 | 330.00 |
| Jun 30, 2025 | -134.00 |
| Mar 31, 2025 | -267.00 |
| Dec 31, 2024 | -375.00 |
| Sep 30, 2024 | -130.00 |
| Jun 30, 2024 | -96.00 |
| Mar 31, 2024 | 2,971.00 |
| Dec 31, 2023 | -85.00 |
| Sep 30, 2023 | 2,359.00 |
| Jun 30, 2023 | -108.00 |
| Mar 31, 2023 | -135.00 |
| Dec 31, 2022 | 605.00 |
| Sep 30, 2022 | -366.00 |
| Jun 30, 2022 | 142.00 |
| Mar 31, 2022 | 2,329.00 |
| Dec 31, 2021 | 168.00 |
| Sep 30, 2021 | -20.00 |